Tag: Catalyst Pharmaceuticals

June 12, 2019

Catalyst Pharmaceuticals Files Lawsuit Against FDA Over Rival Drug

The company is suing the regulatory agency over the approval of Jacobus Pharmaceutical's rival drug Ruzurgi.
May 19, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Index in Green

Last week's top NASDAQ biotech and pharma stocks were Harrow Health, Sesen Bio, Zynerba Pharmaceuticals, Athersys and Catalyst Pharmaceuticals.
December 18, 2018

Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets

Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...
March 29, 2018

Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse

Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...
March 15, 2018

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results

Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...
February 13, 2018

Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse

Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...
January 8, 2018

Top Pharma Stocks of 2017

INN has compiled a list of the top performing pharma stocks of 2017.